logo

ALBANY MOL(NSDQ:AMRI)
Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.
# Employees: 1357
Address: 21 Corporate Circle P.O. Box 15098,Albany,NY,USA
Phone: 518 464-0279
Fax: 518 464-0257
Website: www.albmolecular.com
Email: Peter.jerome@amriglobal.com
Sector: Construction
Industry: ENGINRG/R&D SVS
Executive Officers
Thomas E. D'Ambra Ph.D. (Chmn.; Pres.; C.E.O.; Dir.)
Mark T. Frost (C.F.O.; Treas.)
Paul S. Anderson Ph.D. (Dir.)
Donald E. Kuhla Ph.D. (Dir.)
Kevin O'connor (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2009
Next Earnings Date(Expected): 5/5/2010
Mean EPS (Next Qtr): $0.05
Mean EPS (Year): $0.06
Mean Estimate(Long Term): $13.00
P/E Ratio(Based on EPS estimate): 132.460
Number of Estimates: 2
Shares Performance
Period AMRI Compare to S&P
YTD -5.18 % -8.05 %
4 Weeks -2.60 % -8.91 %
12 Weeks -4.97 % -8.89 %
Shares Information
Analyst Coverage: Y
Avg Volume: 45047
Shares Outstanding: 31M
Market Cap: $0.27B
52 Week High: $10.23
52 Week Low: $7.48
P/E Ratio: -0.010
PEG Ratio: 10.190
Split: On 8/25/2000 AMRI split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -200.00 %
EPS Growth in Last Year: -160.00 %
Sales Growth in Last Quarter: -8.92 %
Sales Growth in Last Quarter: -23.01 %
Financials
Qtr Book Value: $0.87
Cash Flow/Share: $7.17
Change in Payout Ratio: -0.010
Price/Sales: 1.390
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia